Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer-Reference-Cited by-同舟云学术

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer

Published:2021-07-29 Issue:5 Volume:385 Page:395-405
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Gnant Michael¹^ORCID,Fitzal Florian¹,Rinnerthaler Gabriel¹,Steger Guenther G.¹,Greil-Ressler Sigrun¹,Balic Marija¹,Heck Dietmar¹,Jakesz Raimund¹,Thaler Josef¹,Egle Daniel¹,Manfreda Diether¹,Bjelic-Radisic Vesna¹,Wieder Ursula¹,Singer Christian F.¹,Melbinger-Zeinitzer Elisabeth¹,Haslbauer Ferdinand¹,Sevelda Paul¹,Trapl Harald¹,Wette Viktor¹,Wimmer Kerstin¹,Gampenrieder Simon P.¹,Bartsch Rupert¹,Kacerovsky-Strobl Stephanie¹,Suppan Christoph¹,Brunner Christine¹,Deutschmann Christine¹,Soelkner Lidija¹,Fesl Christian¹,Greil Richard¹

Affiliation:

1. From the Comprehensive Cancer Center (M.G., C.F.S., C.D., F.F., K.W., S.K.-S.), the Department of General Surgery (F.F., K.W., S.K.-S.), the Department of Internal Medicine I, Division of Oncology (G.G.S., R.B.), and the Department of Obstetrics and Gynecology (C.F.S., C.D.), Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group (M.G., R.J., L.S., C.F.), Breast Care Center, Hanusch Hospital (U.W.), the Department of Gynecology, Hospital Hietzing, and Karl Landsteiner Institute...

Funder

AstraZeneca

ABCSG

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2104162

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms of pelvic organ prolapse influenced by FBLN5 via FOSL1/miR-222/MEIS1/COL3A1 axis;Cellular Signalling;2024-02

2. Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?;Breast Cancer Research and Treatment;2024-01-25

3. A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors;npj Breast Cancer;2024-01-20

4. Data driven analysis of aromatase inhibitors through machine learning, database mining and library generation;Chemical Physics;2024-01

5. Aromatase inhibitors: the journey from the state of the art to clinical open questions;Frontiers in Oncology;2023-12-22